as the first therapy to help people manage their weight and reduce cardiovascular risks, Martin Holst Lange, executive vice president and head of development at Novo Nordisk, said in a separate statement
Inflammation 43, 11841200
Because of their substantial benefit on some of the most highly prevalent disorders worldwide, GLP-1RAs have been hailed as game changers 8,9 and breakthrough drugs 10 , with an estimated market value of US$22.4 billion in 2022 and a compound annual growth rate of around 9.6% between 2023 and 2032 11
The development of low-cost generic drugs and new delivery methods (such as oral formulations) is the key to solving this problem
5 mg / 2 mL = 2.5 mg/mL 2,000 mcg / 2,500 mcg per mL = 0.8 mL 0.8 mL x 100 = 80 U-100 units Choosing BAC water for a retatrutide titration Retatrutide protocols usually start low and step up over several weeks, so it helps to pick a reconstitution volume that keeps both early and later doses on readable unit marks
This efficacy/security gap suggests that orforglipron is unlikely to significantly erode the market share of subcutaneous formulations